New pain drug tested with HIV pill in healthy volunteers
NCT ID NCT07570069
First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 4 times
Summary
This early-stage study is testing how a new pain medication called suzetrigine interacts with efavirenz, a drug used to treat HIV. The trial involves 18 healthy adults and measures how the body processes suzetrigine when taken alone versus with efavirenz. The goal is to check for any safety issues or changes in drug levels, not to treat pain directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Suzetrigine (also called SUZ, Journavx) and efavirenz
What this could lead to
If successful, this study could help doctors understand how to safely combine suzetrigine with other drugs that affect the same liver enzymes.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels and safety, not whether suzetrigine works for pain. Results may not apply to people with medical conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON - Utah - Salt Lake City Office
Salt Lake City, Utah, 84124, United States